Profile image
Story Views

Last Hour:
Last 24 Hours:

Gastrointestinal Stromal Tumor Therapeutics Industry Report H2 2016 -with Featured News and Press Releases

Monday, November 28, 2016 3:09
% of readers think this story is Fact. Add your two cents.

Gastrointestinal Stromal Tumor Pipeline Review, H2 2016, latest research study provides in depth analysis on Cellular Tumor Antigen P53 (Tumor Suppressor P53 or Antigen NY-CO-13) targeted pipeline therapeutics.

Gastrointestinal Stromal Tumor therapeutics industry report provides comprehensive information on the therapeutics under development for Gastrointestinal Stromal Tumor, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Gastrointestinal Stromal Tumor and features dormant and discontinued projects.

Browse more detail information about Gastrointestinal Stromal Tumor market report at:


Gastrointestinal stromal tumors (GISTs) are tumors, which occur in the gastrointestinal tract. Gastrointestinal stromal tumors belong to a group of cancers called soft tissue sarcoma. GISTs can be benign or malignant tumors. The symptoms of GIST include pain or discomfort in the abdomen, a mass in the abdomen that can feel with the hand, nausea and vomiting, vomiting blood or having blood in the stool and fatigue due to anemia (low red blood cell counts). Gastrointestinal stromal tumor treatment involves the use of surgery, radiation therapy, targeted therapy and chemotherapy.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key players in Gastrointestinal Stromal Tumor – Pipeline Review, H2 2016:
AB Science SA

Advanced Accelerator Applications S.A.

Advenchen Laboratories, LLC

Ariad Pharmaceuticals, Inc.

Arog Pharmaceuticals, Inc.

ArQule, Inc.

Array BioPharma Inc.

Astex Pharmaceuticals Inc

Blueprint Medicines Corporation

Boston Biomedical, Inc.

Calithera Biosciences, Inc.

Chipscreen Biosciences Ltd

Daiichi Sankyo Company, Limited

Deciphera Pharmaceuticals, LLC

Get a PDF Sample of Gastrointestinal Stromal Tumor Market Research Report at:

Drug Profiles of Included in Gastrointestinal Stromal Tumor Therapeutics Development Market Report



And other drug profiles

Have any query? ask our expert @

Key Topics Covered:
2.Gastrointestinal Stromal Tumor Overview
3.Gastrointestinal Stromal Tumor Therapeutics Development
4.Pipeline Products for Gastrointestinal Stromal Tumor – Overview
5.Pipeline Products for Gastrointestinal Stromal Tumor – Comparative Analysis
6.Gastrointestinal Stromal Tumor – Therapeutics under Development by Companies
7.Gastrointestinal Stromal Tumor – Therapeutics under Investigation by Universities/Institutes
8.Gastrointestinal Stromal Tumor Products Glance
9.Late Stage Products
10.Clinical Stage Products
11.Early Stage Products
12.Gastrointestinal Stromal Tumor – Products under Development by Companies
13.Gastrointestinal Stromal Tumor – Products under Investigation by Universities/Institutes
14.Gastrointestinal Stromal Tumor – Companies Involved in Therapeutics Development
15.Gastrointestinal Stromal Tumor Drug Profiles
16.Gastrointestinal Stromal Tumor Dormant Projects
17.Gastrointestinal Stromal Tumor Discontinued Products
18.Gastrointestinal Stromal Tumor Featured News & Press Releases
And Continue…

Get Discount on Gastrointestinal Stromal Tumor Market Research Report at:

This research study help to:
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Gastrointestinal Stromal Tumor
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Gastrointestinal Stromal Tumor pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

About Absolute Report:

Absolute Reports is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in depth market research. We are one of the top report resellers in the market, dedicated towards bringing you an ingenious concoction of data parameters.


Mr. Ameya Pingaley

Absolute Reports

+1-408 520 9750

Email –

We encourage you to Share our Reports, Analyses, Breaking News and Videos. Simply Click your Favorite Social Media Button and Share.

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global

Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.